Yatırımcı.AI

ECILC vs TRILC Comparison

Price, market cap, valuation, profitability and leverage metrics of ECILC and TRILC side by side.

ECILCTRILC
StockFund

If You Had Invested TRY 10,000

Metric Comparison

ECILC vs TRILC Comparison
MetricECILCTRILCSector median
Last price (TL)63.550.9018.72
Daily change−7.23%0.00%−6.36%
Market capTRY 43.5BTRY 933.3MTRY 4.3B
P/B0.680.471.09
Dividend yield2.04%—0.90%
Return on equity−3.08%−4.59%1.78%
Free float22.02%73.16%37.21%
Ratios are calculated from the latest published financial statements.

Popular Comparisons

Related Pages

About the ECILC vs TRILC Comparison

Price, market cap, valuation multiples, profitability and leverage of ECILC (Eczacıbaşı İlaç) and TRILC (Türk İlaç Serum) side by side as of Sep 28, 2026, 14:17. Of the 15 metrics compared, ECILC leads in 8 and TRILC leads in 7.

Highlights: Daily change: TRILC leads (0.00% vs −7.23%). Market cap: ECILC leads (TRY 43.5B vs TRY 933.3M). P/B: TRILC leads (0.47 vs 0.68). EV/EBITDA: TRILC leads (3.67 vs 165.19). EV/Sales: TRILC leads (3.61 vs 9.35). Gross margin: ECILC leads (37.83% vs 25.29%). EBITDA margin (annual): TRILC leads (27.80% vs 11.49%). Net margin (annual): TRILC leads (−1.65% vs −20.86%).

Frequently Asked Questions

By P/E, Tie is cheaper (— vs —); by P/B, TRILC trades at the lower multiple (0.68 vs 0.47).

Annual net margin is −20.86% for ECILC and −1.65% for TRILC; return on equity is −3.08% for ECILC and −4.59% for TRILC.

The leverage ratio is 18.92 for ECILC and 76.53 for TRILC; net debt/EBITDA is 1.37 for ECILC and 2.88 for TRILC. Lower values mean less leverage.

Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.